Source link : https://newshealth.biz/health-news/resistant-dermatomyositis-improves-quickly-significantly-with-combination-drug/
DENVER — Treatment-resistant dermatomyositis improved significantly with the investigational TYK2/JAK1 inhibitor brepocitinib, according to a randomized trial. The higher of two doses of brepocitinib improved the total dermatomyositis score by almost 50% at 1 year as compared with placebo. The novel therapy demonstrated superiority over placebo across all nine secondary endpoints, including skin disease, glucocorticoid […]
The post Resistant Dermatomyositis Improves Quickly, Significantly With Combination Drug first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-29 18:59:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8